Benlysta 200 MG/ML autoinjectml
Ended Awarded Last action
- Contract number
- SPE2DR26FM37G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,973
Award facts
- Contract value 100% obligated
- $6,973.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $6,973.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200 mg/ml Benlysta auto-injector medication on January 9, 2026, with completion targeted for February 2, 2026. The award was made on a non-set-aside, competitive basis and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
Benlysta (belimumab) is a biologic medication used to treat systemic lupus erythematosus and lupus nephritis in military beneficiaries and veterans. The delivery order fulfills the Department of Defense's need for specialty pharmaceutical supplies through the DLA's medical supply chain, supporting military treatment facilities and veterans' healthcare programs. AmerisourceBergen's position as a critical pharmaceutical distributor for federal medical procurement, combined with its established relationship with DLA through the broader IDC, demonstrates the company's capability to efficiently deliver specialized medications required by government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FM37G?
SPE2DR26FM37G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FM37G worth?
The government has obligated $6,973 on SPE2DR26FM37G.
Is contract SPE2DR26FM37G an order under another contract?
Yes. SPE2DR26FM37G is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM37G competed?
The extent of competition for SPE2DR26FM37G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award